Regional · North America

About the North America category

Regional › North America FDA compounding insurance

Pinned Wiki

KLindqvistTL4 Moderator22 Sep 2025#1

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by hana.sato on 25 Feb 2026.

26 Sep 2025 — KLindqvist: Removed a claim that the cited source did not support.
7 Nov 2025 — mira.patel: Replaced an unsourced figure with the published one and cited it.
25 Feb 2026 — hana.sato: Added the worked example and a unit label to the table header.

Editors: KLindqvist, mira.patel, hana.sato

Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

US and Canadian regulation, compounding, and coverage.

This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope described here has drifted from what actually gets posted, edit it rather than starting a topic about it.

What belongs here

Questions specific to north america, with the units and the context stated.
Reports and datasets, with the collection method stated.
Disagreement about the substance, conducted in public.

What belongs elsewhere

Anything urgent belongs in Safety, immediately, and not here.
Anything about how this site works belongs in Meta.
Requests for a maintained page belong in Wiki requests.

Before posting, it is worth checking the documentation commons and this category's tag pages. A great deal of what gets asked here has a maintained answer with a review date on it, which is more reliable than a two-year-old reply.

3 likes 10mo

t.vasquezTL4 Moderator28 Sep 2025#2

Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Moderation notes for this category, so that nothing about how it is run is a surprise.

Topics get moved into and out of here regularly. A move is not a judgement — the category tree is not obvious from outside and putting a question in the wrong place is expected. When I move something I say so in the topic and the action appears in the public log with the guideline cited.

The two guidelines that come up most often in this category are R2, on supplying a source when asked, and R7, on category placement. Neither is used punitively.

6 likes 10mo

e.kuuselaTL22 Oct 2025#3

As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic list shows you what is recent. The tags show you what is settled.

23 likes 10mo

chromatogramTL4Analytical chemist6 Oct 2025#4

Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for exactly those. Happy to make the edit myself if nobody objects, with a revision note.

0 likes 10mo

n.boatengTL210 Oct 2025#5

KLindqvist, post #1: US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope described here has drifted from what actually gets posted, edit it rather than starting a topic about it. What belongs here Questions… Go to post

Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.

That has held every time I have looked, which is not the same as always.

3 likes in reply to #1 10mo

crossover_reviewTL3Regular13 Oct 2025#6

Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account.

Anyone who has looked at this more carefully, please correct the record.

10 likes 9mo

e.bakkenTL216 Oct 2025#7

Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.

31 likes 9mo

methods_marginTL3Regular19 Oct 2025 · edited#8

crossover_review, post #6: Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. Anyone who has looked at this more carefully, please correct the record. Go to post

Coming back to post #6, because the follow-up matters more than the original answer.

Formulary position changes on a schedule that is published in advance, which means a decision made now may be answering last year's formulary.

0 likes in reply to #6 9mo

This topic was referenced in

Coming back to: Telehealth prescribing models in the USRegional › North America · 30 replies
Second pass at: Coverage in the US: a map of the usual obstaclesRegional › North America · 4 replies

Topic	Participants	Replies	Views	Activity
Coverage in the US: a map of the usual obstacles Regional › North America FDA insurance telehealth compounding Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…	+46	50	7.9k	5mo
Telehealth prescribing models in the US Regional › North America FDA compounding insurance telehealth Telehealth prescribing models in the US Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as evidence on telehealth prescribing models,…	+95	102	6.1k	14mo
State-level differences that actually matter Regional › North America compounding telehealth insurance FDA Solved On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…	+6	10	56k	10mo
Follow-up: State-level differences that actually matter Regional › North America FDA telehealth insurance State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A follow-up question about State-level differences that I did not know to ask the first time.…	+90	96	4.1k	4mo
US compounding rules and how they changed Regional › North America FDA telehealth insurance Closed US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…	+62	68	1.4k	20mo

Related topics — sharing the tags FDA, compounding, insurance

Topic	Participants	Replies	Views	Activity
Coming back to: Official shortage notices and what they authorise Access › Shortages FDA compounding shortage formulary Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. Official shortage notices — I have the observation and I do not trust my…	+85	92	5.5k	11mo
Coverage in the US: a map of the usual obstacles Regional › North America FDA insurance telehealth compounding Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…	+46	50	7.9k	5mo
Substitution between formats during a shortage — what changed since Access › Shortages shortage formulary FDA compounding Solved Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Substitution between formats…	+17	21	2.7k	9d
How shortages have affected compounding permissions Access › Shortages shortage compounding FDA formulary How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to know what people here actually do about shortages,…	+61	71	3.6k	2d
Coverage for the indication versus for the drug Access › Insurance & coverage insurance formulary appeals prior authorisation Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want answered is the second one below. The…	+70	79	18k	14mo

Sponsored Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing → Sponsored GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →

What belongs here

What belongs elsewhere

This topic was referenced in

Suggested topics

Related topics — sharing the tags FDA, compounding, insurance